We calculate the value of pharmaceutical product donations according to the WHO Guidelines for Medicine Donations; for other product donations, we apply their fair value.

The increase in our spending on social engagement is attributable to the expansion of the company's Praziquantel Donation Program (MPDP) and the expansion of the Erbitux® China Patients Aid Program. In the Praziquantel Donation Program, we are partnering with the World Health Organization to combat the worm disease schistosomiasis in African school children. In the Erbitux® China Patients Aid Program we work with the Beijing Red Cross Foundation to provide Erbitux® free-of-charge to low-income patients with colorectal cancer.

As a result of the sharp increase in spending on social engagement in Europe and Emerging Markets, the relative share of spending in North America declined from 2013 onwards.

We assign the motivations for our engagement to categories based on the model of the London Benchmarking Group and the guidelines of the Bertelsmann Foundation for corporate social engagement. Projects that primarily aim to make improvements within the community are classified as "Community investment". Projects that are predominantly aimed at company-relevant factors such as image or personnel recruitment are classified as "Commercial initiatives in the community". "Charitable activities” comprehends any other projects that benefit a charitable organization, but cannot be assigned to either of the other two motivation categories due to missing data or their narrow scope.